You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 34 Issue 8

October 2011

Volume 34, Issue 8

Pages 825–1046

  1. REVIEW ARTICLES

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Review article: the impact of bariatric surgery on gastrointestinal motility (pages 825–831)

      A. Ardila-Hani and E. E. Soffer

      Version of Record online: 19 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04812.x

    2. You have free access to this content
    3. You have free access to this content
      Review article: pancreatic renin–angiotensin systems in health and disease (pages 840–852)

      J. R. A. Skipworth, G. Szabadkai, S. W. M. Olde Damink, P. S. Leung, S. E. Humphries and H. E. Montgomery

      Version of Record online: 19 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04810.x

  2. RANDOMISED CLINICAL TRIALS

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy – a double-blind placebo-controlled study (pages 853–861)

      A. Sanyal, Z. M. Younossi, N. M. Bass, K. D. Mullen, F. Poordad, R. S. Brown, R. P. Vemuru, M. Mazen Jamal, S. Huang, K. Merchant, E. Bortey and W. P. Forbes

      Version of Record online: 17 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04808.x

    2. You have free access to this content
      Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children (pages 862–867)

      Y. Vandenplas, S. G. De Hert and PROBIOTICAL-study group

      Version of Record online: 7 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04835.x

    3. You have free access to this content
    4. You have free access to this content
      Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis (pages 878–887)

      S. S. Olesen, C. Graversen, A. E. Olesen, J. B. Frøkjær, O. Wilder-Smith, H. van Goor, M. Valeriani and A. M. Drewes

      Version of Record online: 16 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04802.x

  3. META-ANALYSES

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer (pages 888–900)

      P. García-Iglesias, A. Villoria, D. Suarez, E. Brullet, M. Gallach, F. Feu, J. P. Gisbert, A. Barkun and X. Calvet

      Version of Record online: 7 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04830.x

    2. You have free access to this content
      Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis (pages 901–910)

      C. K. Triantos, N. M. Koukias, V. N. Nikolopoulou and A. K. Burroughs

      Version of Record online: 22 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04822.x

  4. INFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease (pages 911–922)

      L. S. Kiss, T. Szamosi, T. Molnar, P. Miheller, L. Lakatos, A. Vincze, K. Palatka, Z. Barta, B. Gasztonyi, A. Salamon, G. Horvath, G. T. Tóth, K. Farkas, J. Banai, Z. Tulassay, F. Nagy, M. Szenes, G. Veres, B. D. Lovasz, Z. Vegh, P. A. Golovics, M. Szathmari, M. Papp, P. L. Lakatos and for the Hungarian IBD Study Group

      Version of Record online: 24 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04827.x

    2. You have free access to this content
      Exposure to hookworms in patients with Crohn’s disease: a case-control study (pages 923–930)

      J. Kabeerdoss, S. Pugazhendhi, V. Subramanian, H. J. Binder and B. S. Ramakrishna

      Version of Record online: 17 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04824.x

    3. You have free access to this content
      Crohn’s disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study (pages 931–940)

      K. Elriz, V. Palascak-Juif, F. Joly, D. Seguy, P. Beau, C. Chambrier, M. Boncompain, E. Fontaine, D. Laharie, G. Savoye and E. Lerebours

      Version of Record online: 16 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04806.x

    4. You have free access to this content
      Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease (pages 941–948)

      T. Aomatsu, H. Imaeda, K. Matsumoto, E. Kimura, A. Yoden, H. Tamai, Y. Fujiyama, E. Mizoguchi and A. Andoh

      Version of Record online: 16 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04805.x

  5. HEPATOLOGY

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib (pages 949–959)

      M. Pinter, W. Sieghart, F. Hucke, I. Graziadei, W. Vogel, A. Maieron, R. Königsberg, A. Weissmann, G. Kornek, J. Matejka, R. Stauber, R. Buder, B. Grünberger, M. Schöniger-Hekele, C. Müller and M. Peck-Radosavljevic

      Version of Record online: 24 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04823.x

    2. You have free access to this content
      Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C (pages 960–971)

      Y. Rodríguez-Muñoz, S. Martín-Vílchez, R. López-Rodríguez, Á. Hernández-Bartolomé, M. Trapero-Marugán, M. J. Borque, R. Moreno-Otero and P. Sanz-Cameno

      Version of Record online: 17 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04807.x

    3. You have free access to this content
      Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir (pages 972–981)

      A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse and H. L.-Y. Chan

      Version of Record online: 24 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04833.x

  6. GASTRO-OESOPHAGEAL REFLUX DISEASE

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Distinct proteomic profiles characterise non-erosive from erosive reflux disease (pages 982–993)

      C. Calabrese, V. Marzano, A. Urbani, G. Lazzarini, M. C. Valerii, G. Liguori, S. Di Molfetta, F. Rizzello, P. Gionchetti, M. Campieri and E. Spisni

      Version of Record online: 17 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04801.x

    2. You have free access to this content
      Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease (pages 994–1004)

      C.-S. Hsu, P.-C. Wang, J.-H. Chen, W.-C. Su, T.-C. Tseng, H.-D. Chen, T.-H. Hsiao, C.-C. Wang, H. H. Lin, R.-Y. Shyu and Y.-C. Chao

      Version of Record online: 17 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04817.x

  7. PARENTERAL NUTRITION

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
      Cycled enteral antibiotics reduce sepsis rates in paediatric patients on long-term parenteral nutrition for intestinal failure (pages 1005–1011)

      R. Dobson, C. McGuckin, G. Walker, C. Lucas, P. McGrogan, R. K. Russell, D. Young, D. M. Flynn and A. R. Barclay

      Version of Record online: 28 AUG 2011 | DOI: 10.1111/j.1365-2036.2011.04826.x

  8. COELIAC DISEASE

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
  9. CONSTIPATION

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
  10. LETTERS TO THE EDITORS

    1. Top of page
    2. REVIEW ARTICLES
    3. RANDOMISED CLINICAL TRIALS
    4. META-ANALYSES
    5. INFLAMMATORY BOWEL DISEASE
    6. HEPATOLOGY
    7. GASTRO-OESOPHAGEAL REFLUX DISEASE
    8. PARENTERAL NUTRITION
    9. COELIAC DISEASE
    10. CONSTIPATION
    11. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Antibiotic prophylaxis during bleeding for portal hypertension (pages 1032–1033)

      V. La Mura and J. C. García Pagán

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04796.x

    4. You have free access to this content
      Antibiotic prophylaxis during bleeding for portal hypertension: authors’ reply (pages 1033–1034)

      N. C. Chavez-Tapia, T. Barrientos-Gutierrez, F. Tellez-Avila, K. Soares-Weiser, N. Mendez-Sanchez, C. Gluud and M. Uribe

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04819.x

    5. You have free access to this content
      Is otilonium bromide globally effective in irritable bowel syndrome? (pages 1034–1035)

      M. J. Desborough and A. C. Ford

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04769.x

    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
      Questions about mesalazine and the irritable bowel syndrome: authors’ reply (pages 1037–1038)

      C. N. Andrews and K. P. Rioux

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04829.x

    9. You have free access to this content
      Thiopurine metabolite measurement – not for everyone (pages 1038–1039)

      D. P. van Asseldonk, N. K. H. de Boer and A. A. van Bodegraven

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04814.x

    10. You have free access to this content
      Thiopurine metabolite measurement – not for everyone: authors’ reply (pages 1039–1040)

      Y. González-Lama and J. P. Gisbert

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04832.x

    11. You have free access to this content
      Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases (pages 1040–1042)

      E. McDermott, D. Keegan, B. Hall, E. N. Mhuruchu, S. Murphy, G. Doherty, D. O’Donoghue and H. Mulcahy

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04825.x

    12. You have free access to this content
      Hyperuricemia in non-alcoholic fatty liver disease (pages 1042–1043)

      T. Dogru, H. Genc, S. Tapan and S. Bagci

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04828.x

    13. You have free access to this content
      Hyperuricemia in non-alcoholic fatty liver disease: authors’ reply (pages 1043–1044)

      S. Petta and A. Craxì

      Version of Record online: 20 SEP 2011 | DOI: 10.1111/j.1365-2036.2011.04834.x

    14. You have free access to this content
    15. You have free access to this content

SEARCH

SEARCH BY CITATION